A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 65 Years With Alcohol-related Liver Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

393

Participants

Timeline

Start Date

September 27, 2024

Primary Completion Date

December 8, 2026

Study Completion Date

August 23, 2027

Conditions
Liver Diseases, Alcoholic
Interventions
DRUG

GSK4532990

GSK4532990 will be administered

DRUG

Placebo

Placebo will be administered

Trial Locations (26)

15355

RECRUITING

GSK Investigational Site, Ansan

19014

RECRUITING

GSK Investigational Site, Philadelphia

20122

RECRUITING

GSK Investigational Site, Milan

20162

RECRUITING

GSK Investigational Site, Milan

23249

RECRUITING

GSK Investigational Site, Richmond

24071

RECRUITING

GSK Investigational Site, León

24127

RECRUITING

GSK Investigational Site, Bergamo

33016

RECRUITING

GSK Investigational Site, Miami Lakes

33511

RECRUITING

GSK Investigational Site, Brandon

39011

RECRUITING

GSK Investigational Site, Santander

46014

RECRUITING

GSK Investigational Site, Valencia

46202

RECRUITING

GSK Investigational Site, Indianapolis

48202

RECRUITING

GSK Investigational Site, Detroit

70072

RECRUITING

GSK Investigational Site, Marrero

78215

RECRUITING

GSK Investigational Site, San Antonio

78503

RECRUITING

GSK Investigational Site, McAllen

85224

RECRUITING

GSK Investigational Site, Chandler

90033

RECRUITING

GSK Investigational Site, Los Angeles

J6X 4P7

RECRUITING

GSK Investigational Site, Terrebonne

286-8520

RECRUITING

GSK Investigational Site, Chiba

760-0017

WITHDRAWN

GSK Investigational Site, Kagawa

07061

RECRUITING

GSK Investigational Site, Seoul

442-723

RECRUITING

GSK Investigational Site, Suwon Gyeonggi-do

08036

RECRUITING

GSK Investigational Site, Barcelona

G51 4TF

RECRUITING

GSK Investigational Site, Glasgow Strathclyde

W2 1NY

RECRUITING

GSK Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT06613698 - A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 65 Years With Alcohol-related Liver Disease | Biotech Hunter | Biotech Hunter